New Zealand’s cancer patients
may soon have access to
melanoma treatment Keytruda
(pembrolizumab) with the country’s
Pharmaceutical Management
Agency, Pharmac, issuing a
consultation proposal to fund the
product from 01 Sep.
This follows Pharmac’s earlier
decision to fund Keytruda rival
Opdivo from today.
The agency said it “has worked
constructively with supplier,
Merck Sharp & Dohme (MSD) to
reach a favourable commercial
arrangement”.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 16
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.